BYDUREON (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the BYDUREON drug offered from AstraZeneca Pharmaceuticals LP. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
| NON-PROPRIETARY NAME: | exenatide |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-02-01 |
| END MARKETING DATE: | 0000-00-00 |
BYDUREON HUMAN PRESCRIPTION DRUG Details:
| Item Description | BYDUREON from AstraZeneca Pharmaceuticals LP |
| LABELER NAME: | AstraZeneca Pharmaceuticals LP |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2015-02-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0310-6520_c5d95af9-9f58-4914-8863-0edb666e39a2 |
| PRODUCT NDC: | 0310-6520 |
| APPLICATION NUMBER: | NDA022200 |